EUVIMED · CrossrefZeitschrift
Taiwanese Journal of Obstetrics and Gynecology
ISSN 1028-4559 · Elsevier BV
Neueste Artikel
The addition of bevacizumab to combination chemotherapy in patients with recurrent, persistent, or metastatic cervical cancer: Aretrospective single-arm study
Frequency of mismatch repair deficiency for primary endometrial neuroendocrine carcinoma and its therapeutic outcome in Japan
The evolving treatment paradigm of locally advanced cervical cancer (LACC) recurrent, advanced, metastatic and persistent (RAMP) cervical cancer
Prenatal diagnosis of a familial 4q12q13.1 duplication with segmental amplification of the ADGRL3 gene in a pregnancy associated with asymptomatic family carrier members
Impact of pre-labour second twin presentation on early neonatal outcomes in vaginal twin delivery
Impact of prenatal maternal LDH levels on adverse pregnancy outcomes in women with hypertensive disorders during pregnancy
Identification of preeclampsia-associated immune-related risk loci in the Chinese population
Can a single injection replace days of patient-controlled analgesia after cesarean section?
45,X/47,XXX at amniocentesis and detection of disomy X cell line by fluorescence in situ hybridization in uncultured amniocytes and various tissues in a pregnancy with a favorable fetal outcome and perinatal decrease of the 45,X cell line
Is an established treatment suggestion in advanced-stage endometrial cancer fitting to all?
Revisiting the role of GDF-15 in gestational diabetes: Still a hero or a villain?
First trimester pre-eclampsia screening using FMF-UtA-PAPPA algorithm in Hong Kong: A low-cost alternative to PlGF
The minimally invasive gynecology in the AI era
A potential antibody-drug conjugate targeting CDH6 (R-DXd) for chemo-resistant recurrent ovarian cancer
Low-level mosaicism for 45,X in 45,X/46,XX at amniocentesis in a pregnancy with positive non-invasive prenatal testing for Turner syndrome, postnatal progressive decrease of the 45,X cell line and a favorable fetal outcome
Low-level mosaicism for 45,X in 45,X/46,XX at amniocentesis in a pregnancy associated with postnatal progressive decrease of the 45,X cell line and a favorable fetal outcome
Low-level mosaicism for 45,X in 45,X/46,XX at amniocentesis associated with a favorable fetal outcome and postnatal progressive decrease of the 45,X cell line in a pregnancy
Low-level mosaic trisomy 21 at chorionic villus sampling, amniocentesis and cordocentesis in a pregnancy associated with positive non-invasive prenatal testing for trisomy 21 and normal karyotype in the peripheral blood and normal molecular cytogenetic results in the buccal mucosal cells at age 7½ months in the neonate with a favorable fetal outcome
High-level mosaicism for 45,X in 45,X/46,XY at amniocentesis in a pregnancy associated with perinatal progressive decrease of the 45,X cell line and a favorable fetal outcome
High-level mosaicism for 45,X in 45,X/46,XX at amniocentesis in a pregnancy associated with perinatal progressive decrease of the 45,X cell line and a favorable outcome in the fetus
High-level mosaicism for 45,X in 45,X/46,XX at amniocentesis in two pregnancies associated with perinatal progressive decrease of the 45,X cell line and favorable fetal outcomes
Increased risk of ischemic stroke in cervical cancer patients received radiotherapy: A nationwide population-based study
From the margins to the mainstream: The quiet force in innovation of minimally invasive therapy
Usefulness for confirmation of the existence of the disomy X cell line by application of fluorescence in situ hybridization in uncultured amniocytes during repeat amniocentesis for the investigation of 45,X/47,XXX at amniocentesis in a pregnancy with a favorable fetal outcome and perinatal progressive decrease of the 45,X cell line
The role of complete blood test to predict prognosis
Secondary cytoreductive surgery (S-CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent ovarian cancer: Current evidence and clinical perspectives
Immunology and therapeutic strategies in ovarian cancer
High-level mosaicism for 45,X in 45,X/46,X,idic(Y)(q11.2) at amniocentesis in a pregnancy with a favorable fetal outcome and postnatal progressive decrease of the 45,X cell line
The role of secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treating recurrent ovarian cancer
Endometrial cancer: Hypothesis of WANG immunohistochemistry-based molecular classification of endometrial cancer (WANG-EC-Mol)
EUVIMED